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ABSTRACT 
Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of excess hepatic fat, 
exceeding 5% of total liver mass. NAFLD is present in one-third of Americans and up to 90% in those who 
are obese. NAFLD develops largely in part to consumption of a Western diet, defined as 40-60% kcal from 
saturated fats; however, a diet rich in fish-oils may prevent and reverse the development of steatosis.  
PURPOSE: To determine the effects of fish oils on the development of NAFLD.  METHODS: C57BL/6 
(n=91) mice were randomly assigned to four dietary groups for 32-weeks: 10% lard (LFL), 10% fish-oil 
(LFFO), 41% lard (HFL), or 41% fish-oil (HFFO) diet. Significant differences (p<0.05) between groups were 
identified by a one-way ANOVA. RESULTS:  When compared to HFFO, mice in the HFL group saw an 
greater (Table 1) body mass and net glucose AUC by 13% (p<0.001) and 24% (p=0.08), respectively. No 
significant difference was observed between LFL and LFFO for body mass, net glucose AUC or HOMA-IR. 
This is interesting given no significant difference was observed between groups for the mean weekly 
caloric intake. HFFO mice showed an 86% lower (p<0.001) total hepatic lipid and 4.8-fold lower (p<0.001) 
hepatic triglyceride concentration when compared to HFL.  HFFO mice also saw a 32% lower (p<0.001) 
total hepatic cholesterol when compared to HFL. There was no significant difference in total hepatic lipids 
between LFL and LFFO. CONCLUSION: Despite for no significant difference in caloric intake between 
high-fat diet groups, consumption of a high-fat diet rich in fish-oils prevented dietary induced obesity, 
insulin resistance and hepatic steatosis. These results suggest that a diet rich in fish-oils have preventative 
effects on the development of NAFLD. 
 
Table 1. Physiological Characteristics Following 32-Week Diet Intervention 
Variables LFL (n=24) LFFO (n=22) HFL (n=21) HFFO (n=24) 
Body mass (g) 35.6 ± 0.7 35.3 ± 0.7 42.9 ± 1.4a,b 37.5 ± 0.6c 
Kcal/mouse/wk 70.0 ± 5.3 70.8 ± 5.9 76.1 ± 6.3 78.2 ± 9.6 
HOMA-IR 5.2 ± 0.5 5.0 ± 0.7 23.8 ± 3.9 a,b 5.5 ± 0.9 c 
Net Glucose AUC  4827.4 ± 445.0 4923.1 ± 353.7 7807.3 ± 732.5 a,b 5975.0 ± 552.6 
Liver Total Lipid (%) 7.9 ± 0.6 6.9 ± 0.3 13.4 ± 0.9 a,b 7.2 ± 0.3c 
Liver Tg (µg/mg) 16.3 ± 1.9 10.0 ± 1.0 34.3 ± 4.0 a,b 5.9 ± 0.9a,c 
Liver Chol (µg/mg) 3.4 ± 0.2 3.4 ± 0.2 5.4 ± 0.3 a,b 3.7 ± 0.2 c 
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Data are mean ± SD. a Significantly (p<0.05) different than LFL, b significantly (p<0.05) different than LFFO, 
c significantly (p<0.05) different than HFL. 
 
